−173.84 MCHF
743.70 MCHF
146.24 M
About EVOTEC
Sector
CEO
Mario Eugenio Cosimino Polywka
Headquarters
Hamburg
Website
Employees (FY)
4.95 K
Founded
1998
ISIN
DE0005664809
FIGI
BBG006TLPSS9
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.
Big pullback and off to new highs?This one had an insane run the last couple month. Here comes the first bigger pullback this year. Is it a sign of weakness? I dont think so. I believe, it was just profits taken.
So I will ride the trend again, and follow the price to where it has never been (with this stock).
Wait how Price reac
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EVT is 26.96 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange EVOTEC stocks are traded under the ticker EVT.
EVOTEC is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
EVT stock is 0% volatile and has beta coefficient of 1.37. Check out the list of the most volatile stocks — is EVOTEC there?
EVT earnings for the last quarter are −0.21 CHF per share, whereas the estimation was −0.06 CHF resulting in a −266.67% surprise. The estimated earnings for the next quarter are 0.01 CHF per share. See more details about EVOTEC earnings.
EVOTEC revenue for the last quarter amounts to 189.95 M CHF despite the estimated figure of 170.56 M CHF. In the next quarter revenue is expected to reach 192.38 M CHF.
Yes, you can track EVOTEC financials in yearly and quarterly reports right on TradingView.
EVT net income for the last quarter is −37.70 M CHF, while the quarter before that showed −14.58 M CHF of net income which accounts for −158.53% change. Track more EVOTEC financial stats to get the full picture.
Today EVOTEC has the market capitalization of 1.67 B, it has decreased by 8.39% over the last week.
No, EVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EVOTEC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 4.95 K employees. See our rating of the largest employees — is EVOTEC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EVOTEC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EVOTEC stock shows the buy signal. See more of EVOTEC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on EVOTEC future price: according to them, EVT price has a max estimate of 34.83 CHF and a min estimate of 18.22 CHF. Read a more detailed EVOTEC forecast: see what analysts think of EVOTEC and suggest that you do with its stocks.